NASDAQ : COCH
Envoy Medical, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 6.5 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 50.18M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 51.18M |
| Enterprise Value | 32.31M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 7.72M |
| Shares Outstanding | 7.72M |
| Shares Change (YoY) | +177.04% |
| Shares Change (QoQ) | +50.92% |
| Owned by Insiders (%) | 30.83% |
| Owned by Institutions (%) | 13.57% |
| Float | 4.32M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 247.25 |
| Forward PS | 138.32 |
| PB Ratio | 13.85 |
| P/TBV Ratio | 13.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 156.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.73 |
| Quick Ratio | 1.56 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -49.75 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -86.53% |
| Return on Invested Capital (ROIC) | -842.11% |
| Return on Capital Employed (ROCE) | -207.08% |
| Weighted Average Cost of Capital (WACC) | 15.45% |
| Revenue Per Employee | $4,404 |
| Profits Per Employee | -$605,468 |
| Employee Count | 47 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.51 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.95 |
| 52-Week Price Change | -15.48% |
| 50-Day Moving Average | 6.86 |
| 200-Day Moving Average | 6.87 |
| Relative Strength Index (RSI) | 50.80 |
| Average Volume (20 Days) | 21,775 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 577,087 |
| Short Previous Month | 497,969 |
| Short % of Shares Out | 7.48% |
| Short % of Float | 13.35% |
| Short Ratio (days to cover) | 8.41 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 207,000 |
| Gross Profit | -608,000 |
| Operating Income | -23.43M |
| Pretax Income | -23.40M |
| Net Income | -28.46M |
| EBITDA | -23.13M |
| EBIT | -23.43M |
| Loss Per Share | -$5.09 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 19.68M |
| Total Debt | 810,000 |
| Net Cash | 18.87M |
| Net Cash Per Share | $2.44 |
| Equity (Book Value) | 3.69M |
| Book Value Per Share | 0.48 |
| Working Capital | 9.28M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -21.53M |
| Capital Expenditures | -178,000 |
| Depreciation & Amortization | 303,000 |
| Net Borrowing | -879,000 |
| Free Cash Flow | -21.71M |
| FCF Per Share | -$2.81 |
Margins
| Measure | Value |
|---|
| Gross Margin | -293.72% |
| Operating Margin | -11,319.32% |
| Pretax Margin | -11,304.83% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -177.04% |
| Shareholder Yield | -177.04% |
| Earnings Yield | -76.82% |
| FCF Yield | -42.42% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $21.67 |
| Price Target Difference | 226.85% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 231.13% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 26, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -20.79 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |